Abstract:The risk of developing Alzheimer's disease (AD) is almost double in patients with insulin resistance. Prolong hyperinsulinemia is a major cause of insulin resistance. We presented in last year that peripheral hyperinsulinemia and insulin resistance alters the biology and function in neurons at early stages. Mechanistically, we showed that failure of prompt glucose metabolism due to loss of hexokinase-2 (HK2) impairs a multi-step pathway that results in reactivation of cell cycle machinery, as well as accumulation of signals of phosphorylated tau and amyloid. Despite all these cellular findings, it is important to address these series of events in vivo, and their consequences on animal behavior. Assays including behavioral analyses in young (3-month) versus aged (22-44 month) wild type mice (N=24) were performed. Stereotaxic injections of adeno-associated virus (AAV) that carries shRNA against HK2 were performed in hippocampal CA1 region of young non-insulin resistant wildtype mice. Behavioral, immunohistochemistry and a variety of cellular and biochemistry methods were performed to analyze changes occurred in these animals. Here we report that insulin resistant neurons eventually become senescent, a consequence of aberrant reactivation of cell cycle machinery. At behavioral level, insulin resistant animals showed cognitive decline and memory impairment, both were inter-correlated to the severity of peripheral insulin resistance and the senescent load in the brain. Mechanistically, the importance of neuronal glycolysis was validated in vivo. Similar behavioral changes were recapitulated in young non-insulin resistant animals with HK2 knockdown in CA1 neurons. Notably, these neurons also showed aberrant cell cycle re-activation and expressed a senescent phenotype. These findings therefore extended our understanding on how peripheral hyperinsulinemia and insulin resistance alters the biology and function of the brain, particularly at behavioral levels. At basic science level, our data also offer a mechanism on how post-mitotic neurons could become senescent—an outcome of aberrant cell cycle reactivation. At translational level, this study re-emphasizes that metabolic syndrome like peripheral insulin resistance is a modifiable risk factor for AD. Better management of insulin resistance is therefore a important strategy to prevent related neurodegeneration events and potential initiation of AD.

Upregulation of NADPH-oxidase, inducible nitric oxide synthase and apoptosis in the hippocampus following impaired insulin signaling in the rats: Development of sporadic Alzheimer's disease

[The Investigation of Syn and NPY Expression in Brain Tissues of Diabetic Model Rat Induced by Streptozotocin].

Intranasal Insulin Ameliorates Cerebral Hypometabolism, Neuronal Loss, and Astrogliosis in Streptozotocin-Induced Alzheimer’s Rat Model

Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer’s rat model

Targeting Insulin Signaling for the Treatment of Alzheimer's Disease.

A High-sugar High-fat Diet Induced Metabolic Syndrome Shows some Symptoms of Alzheimer's Disease in Rats

Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe/PS1dE9 mice.

Aging Patterns of Neuronal Nitric Oxide Synthase in Hippocampus of Senescence Accelerated Mouse

Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer’s Disease (sAD)-Like Pathology

Impaired Learning and Memory Ability Induced by a Bilaterally Hippocampal Injection of Streptozotocin in Mice: Involved With the Adaptive Changes of Synaptic Plasticity

INSULIN RESISTANT NEURONS ARISEN FROM PERIPHERAL HYPERINSULINEMIA ARE SENESCENT AND CORRELATE WITH MEMORY IMPAIRMENT AND COGNITIVE DECLINE: IMPLICATIONS FOR ALZHEIMER’S DISEASE

Hippocampal sharp-wave ripples and hippocampal-prefrontal synchrony regulate memory-enhancing effects of intranasal insulin in an STZ-induced Alzheimer's model

AD-Like Neuropsychiatric Dysfunction in a Mice Model Induced by a Combination of High-Fat Diet and Intraperitoneal Injection of Streptozotocin

Hippocampal insulin resistance and the Sirtuin 1 signaling pathway in diabetes-induced cognitive dysfunction

Age-related Dysfunction of Insulin Degrading Enzyme (IDE) and Insulin Signaling Pathway and the Reversive Effect of Rosiglitazone

219-OR: Loss of Insulin Signaling in Microglia Impairs Cellular Uptake of Aß and Neuroinflammatory Response Exacerbating Alzheimer-Like Neuropathology

Enhancement of Β-Amyloid Oligomer Accumulation after Intracerebroventricular Injection of Streptozotocin, Which Involves Central Insulin Signaling in a Transgenic Mouse Model

AMPK activation ameliorates Alzheimer's disease-like pathology and spatial memory impairment in a streptozotocin-induced Alzheimer's disease model in rats

Loss of Insulin Signaling in Microglia Impairs Cellular Uptake of Aβ and Neuroinflammatory Response Exacerbating Alzheimer-like Neuropathology

Insulin resistance-induced hyperglycemia decreased the activation of Akt/CREB in hippocampus neurons: Molecular evidence for mechanism of diabetes-induced cognitive dysfunction